https://www.selleckchem.com/pr....oducts/sndx-5613.htm
The role of direct penicillin challenge in patients at low risk is emerging and is the method of choice for children. Patients with an unconfirmed penicillin allergy have a low risk of reacting to cephalosporins. The R1 side chain largely dictates cephalosporin allergy and cross-reactivity. Drug challenge is the preferred method for evaluation of both fluoroquinolone and macrolide allergy. Conclusion Multiple effective methods are available to delabel patients of common antibiotic allergies. Delabeling patients in a proactive manner c